These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1010 related items for PubMed ID: 8942251
1. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs. Wang YM, Ng WC, Kang JY, Yap I, Seet BL, Teo J, Smith R, Guan R. Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251 [Abstract] [Full Text] [Related]
2. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients. Barnaba V, Valesini G, Levrero M, Zaccari C, Van Dyke A, Falco M, Musca A, Balsano F. Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020 [Abstract] [Full Text] [Related]
3. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation]. Bujanda L, García Bengoechea M, Cilla G, Gil I, yArenas JI. Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540 [Abstract] [Full Text] [Related]
4. Hepatitis B virus infection in allogeneic bone marrow transplantation. Ustün C, Koç H, Karayalcin S, Akyol G, Gürman G, Ilhan O, Akan H, Ozcan M, Arslan O, Konuk N, Uysal A, Beksaç M. Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543 [Abstract] [Full Text] [Related]
5. Serological markers of hepatitis B infection in Niue children. Williamson HG, Gust ID, Dimitrakakis M, Liu SQ, Taylor R, Whitmore J, Nemaia HT, Nemaia J. N Z Med J; 1985 Apr 24; 98(777):275-7. PubMed ID: 3857507 [Abstract] [Full Text] [Related]
6. Prevalence of hepatitis B infections in a multiracial New Zealand community. Milne A, Allwood GK, Moyes CD, Pearce NE, Lucas CR. N Z Med J; 1985 Jul 10; 98(782):529-32. PubMed ID: 3861964 [Abstract] [Full Text] [Related]
7. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS). Ogutu EO, Amayo EO, Okoth F, Lule GN. East Afr Med J; 1990 May 10; 67(5):355-8. PubMed ID: 2390958 [Abstract] [Full Text] [Related]
8. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK. J Med Virol; 2009 Sep 10; 81(9):1531-8. PubMed ID: 19623669 [Abstract] [Full Text] [Related]
9. [Anti-HBs-F(ab)'2 to the seroconversion of HBsAg carriers]. An P. Zhonghua Yi Xue Za Zhi; 1992 Nov 10; 72(11):647-50, 701. PubMed ID: 1338699 [Abstract] [Full Text] [Related]
10. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC. Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088 [Abstract] [Full Text] [Related]
11. Some remarks of HBsAg and anti-HBs distribution in symptom-free carriers. Sabău M, Mosley JW, Demeter S. Arch Roum Pathol Exp Microbiol; 1977 Nov 01; 36(3-4):255-61. PubMed ID: 617040 [No Abstract] [Full Text] [Related]
12. Infections with the hepatitis B virus associated delta agent in an isolated West-African community. Goudsmit J, van der Waals F, Ponzetto A, Forzani B, Dobbelaar C. J Trop Med Hyg; 1984 Dec 01; 87(6):257-62. PubMed ID: 6534990 [Abstract] [Full Text] [Related]
13. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation]. Woo SY, Cho SH, Lee SM, Koh MB, Noh CH, Kim CW, Choi JY, Yang JM, Han JY, Lee YS. Korean J Hepatol; 2009 Jun 01; 15(2):131-9. PubMed ID: 19581765 [Abstract] [Full Text] [Related]
14. Hepatitis-B virus infection in rural and urban populations of eastern Nigeria: prevalence of serological markers. Amazigo UO, Chime AB. East Afr Med J; 1990 Aug 01; 67(8):539-44. PubMed ID: 2261867 [Abstract] [Full Text] [Related]
15. [HBeAg and anti-HBe levels in HBsAg positive blood donors]. Hasçelik G, Günalp A. Mikrobiyol Bul; 1989 Jan 01; 23(1):23-9. PubMed ID: 2626096 [Abstract] [Full Text] [Related]
16. Prevalences of hepatitis B surface antigen carriers and liver damages in the general population of Hisayama, Japan. Kajiwara E, Akagi K, Ueda K, Murai K, Hasuo Y, Kiyohara Y, Wada J, Kawano H, Kato I, Fujishima M. Fukuoka Igaku Zasshi; 1992 Jun 01; 83(6):257-61. PubMed ID: 1511951 [Abstract] [Full Text] [Related]
17. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M. Clin Infect Dis; 2007 May 01; 44(9):1161-9. PubMed ID: 17407033 [Abstract] [Full Text] [Related]
18. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen. Tamura I, Shimase K, Ichimura H, Kurimura O, Kaneto E, Tsuchie H, Kurimura T. Acta Virol; 1985 Dec 01; 29(6):505-8. PubMed ID: 2869663 [Abstract] [Full Text] [Related]
19. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. Colson P, Borentain P, Motte A, Henry M, Moal V, Botta-Fridlund D, Tamalet C, Gérolami R. Virology; 2007 Oct 10; 367(1):30-40. PubMed ID: 17573090 [Abstract] [Full Text] [Related]
20. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH. J Pediatr Gastroenterol Nutr; 2009 Feb 10; 48(2):203-8. PubMed ID: 19179883 [Abstract] [Full Text] [Related] Page: [Next] [New Search]